1.
The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice.
2.
3.
Real-world efficacy and safety of apremilast in Belgian patients with psoriatic arthritis : results from the prospective observational APOLO study
Real-World Efficacy and Safety of Apremilast in Belgian Patients with Psoriatic Arthritis: Results from the Prospective Observational APOLO Study.
4.
5.
6.
7.
8.
9.
Real-World Efficacy and Safety of Apremilast in Belgian Patients with Psoriatic Arthritis: Results from the Prospective Observational APOLO Study
Cardiovascular comorbidities in psoriatic arthritis: epidemiology and risk factors in two different European populations.